These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances. Kato M; Sugimoto A; Atsumi T Expert Rev Clin Immunol; 2020 Oct; 16(10):993-1004. PubMed ID: 32975145 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review. Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506 [TBL] [Abstract][Full Text] [Related]
18. [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. Yoshifuji H; Kinoshita H Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):454-61. PubMed ID: 25748129 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review. Ding Y; Qian J; Zhang S; Xu D; Leng X; Zhao J; Wang Q; Zhang W; Tian X; Li M; Zeng X Int J Rheum Dis; 2022 Sep; 25(9):982-990. PubMed ID: 35699128 [TBL] [Abstract][Full Text] [Related]